Rheaply
PrivateLast Round
Series B
Jun 7, 2022
Total Funding Raised
$33.8M
Company Overview
Rheaply is a climate tech and software company that provides a resource exchange platform designed to help organizations manage, share, and reuse physical assets to support the circular economy.
Sector
Enterprise Software
Verticals
Circular Economy, ESG Analytics, Waste Management, Supply Chain Tracking
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rheaply Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Rheaply Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 7, 2022 | ||||
| Grant | Dec 14, 2021 | ||||
| Series A Extension | Jun 23, 2021 | ||||
| Series A | Feb 16, 2021 | ||||
| Grant | Dec 3, 2020 | ||||
Seed | Mar 17, 2020 |
Rheaply Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIT Solve | Series A Extension |
| Concentric Equity Partners | Seed |
| Techstars | Series B, Seed |
| M25 | Series A, Seed |
| Access Ventures | Grant |
| High Alpha | Series B, Series A |
| Salesforce Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 14, 2021
$100K grant from the U.S. Environmental Protection Agency (EPA).
- Jun 23, 2021
$2.2M round led by Microsoft Climate Innovation Fund.
Rheaply Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rheaply's valuation, stock price, and market status.